Background The prevalence of bacterial infection in patients with COVID-19 is low, however,
empiric antibiotic use is high. Risk stratification may be needed to minimize unnecessary …

Background and aims Severe manifestations of coronavirus disease 2019 (COVID-19) are
associated with alterations in blood cells that regulate immunity, inflammation, and …

Background Systemic inflammation indices, including neutrophil/lymphocyte ratio (NLR),
monocyte/lymphocyte ratio (MLR), platelet/lymphocyte ratio (PLR), derived …

Background Cardiovascular disease (CVD), one of the most common comorbidities of
coronavirus disease 2019 (COVID-19), has been suspected to be associated with adverse …

Introduction Young and middle-aged adults are the largest group of patients infected with
SARS-CoV-2 and some of them develop severe disease. Objective To investigate clinical …

Introduction Data regarding patients presenting with severe acute respiratory syndrome
(SARS-CoV-2) illness have not adequately been documented which provides distinct …

Diagnosis and home follow-up of patients affected by COVID-19 is being approached by
primary health care professionals through telephone consultations. This modality of …

Background Outcomes of coronavirus disease 2019 (COVID-19) have been reported to be
different in the young and elderly populations. However, previous studies examining these …

This systematic review and meta-analysis synthesized the evidence on the impacts of
demographics and comorbidities on the clinical outcomes of COVID-19, as well as the …

Introduction. La pandémie à COVID-19 représente un problème mondial de santé publique.
Nous réalisons cette étude pour décrire les aspects épidémiologiques, cliniques …